Viewing Study NCT05274633


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2025-12-31 @ 6:39 PM
Study NCT ID: NCT05274633
Status: COMPLETED
Last Update Posted: 2025-06-12
First Post: 2022-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real Life Use of Ravulizumab in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module